The last decade has seen a swell of biotech startups using AI to design proteins. These are seven companies to watch.

Archon’s AbC technology combines two molecular-based biomedical tools, naturally occurring antibodies and custom-designed proteins, to create a single new protein structure. These protein structures, ...

Georgia Tech researchers created AF2Complex, a deep-learning tool that predicts antibody interactions with proteins, ...

Researchers identified a unique antibody signature against the Epstein ... role of deep learning techniques in revolutionizing protein structure prediction. In this interview, conducted at SfN ...

Archon Biosciences has launched with $20 million to design custom antibody cages with the help of AI. The Seattle-based company spun out of the lab of the 2024 Nobel laureate David Baker at the ...

These proteins became drugs because scientists ... More than just turning a target on or off, the AbC’s structure can adjust how much. Antibodies often require secondary signals to activate.

Archon Biosciences emerges from stealth to advance a new class of biologic invented in Nobel Prize-winning computational ...

The hepatitis E virus affects the liver. But infected liver cells secrete a viral protein that reacts with antibodies in the ...

This year’s Nobel Prize in Chemistry is all about proteins, the chemical building blocks and tools that virtually all living ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei ...

AK132 is a bispecific antibody developed by Akeso, targeting the recombinant humanized Claudin18.2 (CLDN18.2) splice variant 2 and CD47 for the treatment of various cancers, including gastric, ...